Newsletter - October 2014


Be The Match® has a matching stem cell donor for most US patients


Frances Verter, PhD

A suitable cord blood match (HLA match of 4 out of 6 or better) is available from Be The Match for nearly every US patient under age 20 and for more than 80% of patients age 20 and over, regardless of racial or ethnic background. The challenge at this point is how best to apply the limited resources of the Be The Match organization to find matches for the remaining patients, who are predominantly ethnic minorities and mixed race individuals.

In July 2014 the prestigious New England Journal of Medicine published a study of donor-patient match likelihoods in the US stem cell registries. These registries are operated by the National Marrow Donor Program® (NMDP), aka Be The Match®. The likelihoods of donor-patient matching were calculated based on models of the genetic variations in the US population. The research was led by bioinformatics scientists at NMDP, through its research program CIBMTR® (Center for International Blood and Marrow Transplant Research). This study was an NMDP contract deliverable that first appeared as a White Paper presented to the HRSA Advisory Council in June 2010.

It is important to emphasize that the published cord blood matching takes into account the range of weights among patients of various ages and the range of cell doses in the cord blood inventory. The reason that nearly every patient under age 20 can find a match is that the cell dose of the cord blood units in public banks are adequate for almost all pediatric patients. Moreover, over 80% of adult patients can also find a cord blood unit that is big enough and a close enough match for a cord blood transplant.

However, a close enough match is not necessarily what a transplant physician would consider an optimal match. The ideal donor is always a matching sibling, but only 30% of patients have one. Based on current clinical practice, the best donor from a registry search is an adult donor of bone marrow or peripheral blood who matches at 8 out of 8 HLA types.

The three main factors that enter donor selection are: the type of stem cells, the cell dose, and the degree of donor-patient match. First, adult donors of bone marrow and peripheral blood stem cells are currently preferred over stored units of cord blood stem cells because adult donations are quicker to engraft and replenish the patient's immune system. Second, the cell dose required for a cord blood transplant is a minimum of 25 million Total Nucleated Cells (TNC) per kilogram of patient weight, whereas a cell dose 10 times higher can easily be harvested from adult donors. Third, the current clinical standards require an adult donor to match at 8 out of 8 HLA types (abbreviated as 8/8 match) or at least 7/8, while a cord blood unit is considered to be a match at 6/6, but 5/6 and 4/6 are also acceptable.

The upshot of the various matching considerations is that a matching adult donor is more desirable to transplant physicians, but a matching cord blood unit is easier to obtain.

The first step in a registry search for a matching donor is always to seek an 8/8 adult donor. The NMDP registry holds 11 million potential adult donors, and has access to 22 million donors that can be searched through international registries (but the other international donors were not included in the study just published in NEJM) (Reference: NMDP press release).

The NMDP study looked at how well patients of different racial/ethnic groups fared at finding a match. The patient and donor populations were divided into 21 different racial/ethnic groups, based on how people self-identified when they filled out their paperwork.

The odds of finding an 8/8 adult donor are best for White European patients, at 75%. Most racial/ethnic groups fall in the 30-50% range. The lowest probabilities are among Black patients, where the ability to find an 8/8 adult donor ranges between 16% for Blacks of South or Central American descent, 18% for African descent, and 19% for African American or Caribbean descent.

Oftentimes when a patient needs a matching donor, their family will organize a donor drive among persons of similar racial/ethnic background, through community or religious organizations. This strategy is well-founded, because HLA types are inherited. The study confirms that most patients are more likely to find a donor within their own racial and ethnic group than outside. For example, Koreans and Chinese only pick up another 1% chance of finding an adult donor by looking outside their group. But a group that historically has a high degree of racial admixture, for example Hispanics from South and Central America, can find half again as many donors by looking outside their group (Reference: NEJM Appendix Table S2).

If an 8/8 adult donor cannot be found, the next step in the matching strategy is either to look for a 7/8 adult donor, and then try a cord blood search, or else go straight to a cord blood search. If the transplant physician goes straight to a cord blood search, then the majority of matches identified for the patient will be cord blood units, for every racial group except White Europeans. This is illustrated below by NEJM Appendix Figure S3.

The cord blood inventory is currently 193,00 in the NMDP network (NMDP) or 731,280 worldwide (WMDA). Thanks to the less stringent HLA matching requirements with cord blood, this search strategy raises the fraction of adult African American patients who can find a donor to over 80%.

Going forward, how should NMDP/BeTheMatch® invest their resources to build on this success? The registry is projected to grow 9% each year, but the study authors admit that trying to increase the match rates by recruiting more adult donors has reached a stage of "diminishing returns". Moreover, not all of the registered adult donors will actually be available if called to donate. This limitation varies by ethnic group and was factored into the predictions. The authors calculated that outreach efforts to improve donor availability by 5% would have the same impact as two years of recruitment.

The study concluded that growth of the cord blood inventory holds the most promise to narrow the disparity in transplant access between white Europeans and members of those racial/ethnic groups that are minorities in the US.

There remains the clinical challenge that transplant physicians still consider 8/8 adult donors to be optimal, and by this measure many patients who have a cord blood match do not have an optimal donor. But if ongoing research into ways to make cord blood transplants engraft faster are successful, this search strategy should change. If the engraftment concerns were removed, the fact that a matching cord blood unit is immediately available from the bank, and will not have a change of status or a change of mind, would become a more dominant consideration.

NEJM Appendix figure S3


  1. HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
    Loren Gragert, Mary Eapen, Eric Williams, John Freeman, Stephen Spellman, Robert Baitty, Robert Hartzman, J. Douglas Rizzo, Mary Horowitz, Dennis Confer, and Martin Maiers
    N Engl J Med 2014;371:339-48. DOI:10.1056/NEJMsa1311707

Victoria Angel Registry of Hope - Uniquely Helping Canadians

Victoria Angel Registry - IT IS SIMPLE

Jane Virro, co-founder Cells for Life & Victoria Angel

Canada has the most ethnically diverse population in all of the Group of Eight (G-8) leading industrialised countries (1). Over 20% of Canada's population is foreign-born, with representation from almost 200 countries. Among those who arrived since 2001, almost 60% are from Asia (including the Middle East). Currently, 20% of the population identify themselves as members of a visible minority, which accounts for over 6 million people. The median age of this group, 33.4 years, is within the child-bearing years.

Canada prides itself on being a 'mosaic culture' and thus many children are born with mixed ethnicities. As we know, people in this population have a difficult time finding a bone marrow donor; access to cord blood stem cells is vital to this group. So it would make sense for Canada to have a fully developed and effective public cord blood program, but unfortunately this is not the case.

The Canadian government started talking about public cord blood banking in 2006, yet the process was slow. During this time, we decided to act. As the leaders at Cells for Life, one of Canada's largest and most respected family cord blood banks, we recognized that Canada was a top-10 user of cord blood stem cells world-wide (2), yet it had one of the lowest inventories of available samples in the G-8 countries. Our team at Cells for Life felt a personal and professional obligation to help, and thus we founded Victoria Angel Registry of Hope (VAR) public cord blood bank.

Since 2005, we have dedicated a great deal of time and resources as well as a portion of Cells for Life profits to develop the VAR public program. Over time, it was recognized that additional funding was needed to build the bank's inventory faster. In 2012, VAR received charitable status and became a stand-alone public cord blood bank. Currently, the bank's work is mostly supported by fund-raising, with Cells for Life still being one of the largest financial sponsors of the bank.

Victoria Angel Registry of Hope is one of Canada's three public cord blood banks. HémaQuébec cord blood program, supported by the provincial government of Québec, started collecting cord blood in 2004 and now has a network of eight hospitals accepting donations. Canadian Blood Services finally received government funding and opened its first cord blood collection site in Ottawa in September 2013. Canadian Blood Services plans to operate two processing laboratories and collection sites at five hospitals.

VAP 34 collection hospitals

Victoria Angel Registry of Hope accepts donated cord blood from parents delivering at 34 hospitals in the Toronto region. The charity manages donor education, recruitment, and screening, as well as collection and disposition of samples. Services related to cord blood processing and storage are contracted to the Cells for Life laboratory, which is accredited by both AABB and FACT, on a strict cost-recovery basis. VAR's program has passed regulatory inspection by Health Canada, has been accredited by AABB as part of the Cells for Life program, and has a FACT inspection planned in 2015.

Donations stored in the VAR public bank are listed on the international BMDW network for patients seeking donors. Cord blood collections that do not meet the requirements to be saved for transplants are used in a variety of research collaborations. VAR is poised to ramp up operations as funding is received. The infrastructure is in place and all funds donated will go directly toward banking more cord blood.

Victoria Angel's vision is clear - an effective Canadian public cord blood system continues to grow, giving hope and help to patients in need of transplant. This is best developed by embracing, supporting, combining and synchronizing the efforts and expertise of all who work in the field. Victoria Angel Registry of Hope is committed to growing our inventory and doing our part to help Canadians acquire the help and hope they need.


  1. Statistics Canada, most recent report 2011
  2. WMDA Annual Report, 2012